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Abstract
Introduction: Anorexia nervosa (AN) is  a serious psychosomatic  syndrome,  classified as  an
eating disorder. AN patients strive to lose weight below the normal limits defined for a specific
age  and  height,  achieving  their  goal  even  at  the  expense  of  extreme  emaciation.  AN has  a
multifactorial aetiology. Genetic factors are believed to be significant in the predisposition to the
development of AN. In girls suffering from AN significantly lower levels of resistin (RES) in
blood serum are observed as compared to healthy girls. These differences may lead to a thesis
that  functional  genetic  polymorphisms  in  RES  coding  genes  can  be  responsible  for  this
phenomenon. In our pilot study we demonstrated significant differences in the distribution of
genotypes in the  locus  RETN c.-180C>G of the RES gene in 67 girls with AN and 38 healthy
girls. It seems reasonable to compare the frequency of polymorphisms of  RETN  c.62G>A and
RETN c.-180C>G in the RES gene in girls with AN and in healthy subjects in a bigger cohort and
to analyse correlations between individual variants of the polymorphisms referred to above and
the RES levels in blood plasma. 
Material and methods: The study covered 308 girls with the restrictive form of AN (AN) and
164 healthy girls (C) (aged 11–19 years). The RES levels in blood serum were determined by
means of the ELISA method on a Bio-Vendor machine from LLC (Asheville, North Carolina,
USA). The DNA isolation was carried out by means of Genomic Mini AX BLOOD (SPIN). The
PCR reaction was carried out on a ThermoCycle T100 thermocycler. 80–150 ng of the studied
DNA and relevant F and R starters were added to the reaction mixture. The reaction products
were subjected to digestion by restriction enzymes and separated on agarose gels (RFLP). 
Results:  The average RES level in blood serum in the AN group was significantly lower (p <
0.0001) than in the C group. The distribution of genotypes in the locus RETN c.62 of the RES
gene was similar in both groups. A significant difference was demonstrated in the distribution of
genotypes in the polymorphic site RETN c.-180 of the RES gene between AN and C (p = 0.0145)
and in the distribution of the C and G alleles in the locus RETN c.-180 (p < 0.0001). The C allele
occurred significantly more frequently than the G allele in the C group as compared to the AN
group. In all the study subjects jointly (AN and C) a significant positive correlation between the
blood RES levels on one hand and the body mass (r = 0.42; p < 0.0001) and BMI (r = 0.61; p<
0.0001) on the other was observed. There was no correlation between the concentration of RES in
blood serum and the distribution of genotypes in the loci of the resistin gene referred to above. 
Conclusions: The CG genotype in the locus RETN c.-180 C>G of the RES gene may constitute
one of the factors predisposing to the development of AN in girls. The genotype in the loci RETN
c.62 G>A and  RETN  c.-180 C>G of the resistin  gene has no influence on the levels of this
hormone in blood in AN patients. 
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Introduction 
Anorexia nervosa (AN) is  a psychosomatic syndrome classified as one of an eating disorder,
characterised  by  excessive  concentration  on  one’s  body  weight  and  appearance,  as  well  as
abnormal eating patterns and energy expenditure [1].  Anorexia nervosa patients strive to lose
weight below normal limits defined for a specific age and height, achieving their goal even at the
expense of extreme emaciation [2].  Anorexia nervosa diagnostic criteria are determined in the
International Statistical Classification of Diseases and Related Health Problems (ICD-10 — F-50)
[3]. The criteria most often applied for the purposes of scientific research are the ones contained
in the chapter Feeding and Eating Disorders of the fifth edition of Diagnostic and Statistical
Manual of Mental Disorders 5, (DSM-5). DSM-5 distinguishes two forms of AN: restrictive AN
and bulimic-purging AN [4]. This disorder affects ca. 1% of the population of girls and women
aged 15–24 years, and the incidence is estimated at 0.7–1/10,000 women annually [5].
Despite numerous studies devoted to AN, its aetiology remains unclear, and the significance of
specific  pathogenetic  factors  is  controversial.  Authors  agree,  however,  on  the  multifactorial
theory of the disease development. Both individual factors predisposing to the disease (genetic
factors and some personality traits), as well as environmental ones (sociocultural, family-related,
and socioeconomic) may play a role in the aetiopathogenesis of AN. 
The relationship between sociocultural factors and the risk of AN can be suggested by the higher
incidence of AN in western countries, where the cult of the body and health, the model of a slim
figure, and physical fitness are promoted, and at the same time obesity is excessively stigmatised.
In recent years these countries have observed an increase in the incidence of eating disorders, AN
included, by ca. 20–30%. Transcultural studies, however, do not allow us to confirm the thesis
that the effects of western culture are sufficient for AN to develop [6]. 
The  theory  of  the  passive  correlation  of  environmental  and genetic  factors  has  been  raised.
Parents of patients suffering from AN often demonstrate certain common personality traits, such
as  excessive  ambitions,  perfectionism,  and perseverance.  These  qualities,  perhaps  genetically
determined,  are  passed on to  their  offspring.  Nevertheless,  the  significance  of  family-related
factors in AN has not been fully proven; most analyses conducted thus far constitute correlative
studies, not allowing us to draw certain cause and effect conclusions [6].
Research carried out in the last three decades have demonstrated that genetic factors contribute to
the development of AN. Twin and family studies have allowed us to determine the heritability of
eating disorders, i.e. to assess what part of the inter-individual phenotypic variability is dependent
on genotypic variation. According to those studies the heritability of AN is high; it is estimated at
the level of 48–88% [7], which indicates the legitimacy of searching for genes predisposing to
AN. A large study of families, covering 1831 relatives of 504 probands with AN, 177 patients
with  bulimia nervosa, and  181 subjects  from a  control  group,  demonstrated that  first-degree
female  relatives  have  an  at  least  ten-fold  higher  risk  of  developing  full-blown AN than  the
general population [7]. 
Two different strategies to clarify the molecular background of multifactorial diseases such as AN
have been proposed. The first approach is based on candidate gene studies, and the other (the
genome-wide association study — GWAS) is devoted to studying the entire genome, without
making a priori  hypotheses. Differences in the distribution of alleles or genotypes between the
patients and the control group, carefully matched according to ethnicity, suggest a role of the
specific locus in the pathogenesis of the disorder [7]. On the other hand, studies applying linkage
analysis are not conducted on a large scale in AN patients at present due to high costs and logistic
difficulties [6]. 
Numerous attempts to find genetic variants for AN using a candidate gene approach [8–11] failed
to  provide  satisfactory  results  due  to  small  sample  sizes,  methodological  differences,  and
heterogeneity of the studied populations [8]. 
Duncan et al. [12] observed, on the basis of the largest cohort of AN patients studied thus far, that
the strongest genetic correlation among all the studied metabolic and psychological phenotypes is
a negative correlation between anorexia nervosa and insulin resistance.  
The hormone of the adipose tissue participating in the modulation of insulin resistance is resistin
(RES) [13–15]. The resistin coding gene RETN mapped in the region 19p13.2 contains 4 exons
[16, 17]. In humans the RES expression is detected in preadipocytes, minor in the brown adipose
tissue, but its main source are macrophages [17, 18]. In mice some minor expression is detected
in the pituitary gland and the arcuate nucleus of the hypothalamus. RES is suggested to play a
role  in  central  mechanisms  associated  with  food  intake  through  inhibition  of  secretion  of
catecholamines in the hypothalamus [19]. It plays a direct role in causing insulin resistance (the
word “resistin” derives from the phrase “insulin resistance”), as well as indirectly by blocking
adipocyte differentiation — in causing ectopic fat storage in the liver and in the skeletal muscles
[20]. 
The concentration of RES in blood serum positively correlates with body mass and BMI; it drops
during starvation and returns to normal after resuming feeding [21–23]. In girls suffering from
AN a significantly lower concentration of RES in blood serum is found as compared to healthy
girls with normal body weight and obesity [24]. 
Differences in RES levels in blood in subjects with AN as compared to healthy subjects, observed
by numerous authors, led to the hypothesis that functional genetic polymorphism in the RES
coding gene could be responsible for this phenomenon. 
The subject literature available contains only a few works on this topic. Křížova et al. [25], when
studying single alleles in the loci +62G>A and -180C>G of the RES gene found that the presence
of a less frequently occurring G allele in the polymorphic site RETN c.-180C>G may constitute a
protective factor for certain metabolic abnormalities. The authors found a correlation between a
higher BMI in the AN group and less frequent G allele in the site RETN c.-180C>G (p < 0.05). 
In the pilot study we conducted in 2017 in 68 girls suffering from AN and 38 healthy girls [26],
focusing  on  the  incidence  of  polymorphisms  in  adiponectin  and  resistin  genes,  we obtained
encouraging results in sites where functional polymorphisms can be located in the context of
causing  insulin  resistance.  We  demonstrated  significant  differences  in  the  distribution  of
genotypes  in  the  sites  RETN  c.-180C>G  of  the  resistin  gene.  There  were  no  significant
differences in the locus RETN c.62G>A. Hence it seems legitimate to continue research in this
scope in a bigger cohort,  assuming that perhaps one of the genotypes in the locus RETN  c.-
180C>G  of  the  resistin  gene  could  constitute  a  factor  predisposing  to  the  development  of
anorexia nervosa. 
The objective of the present study is to compare the frequency of RETN c.62G>A and RETN c.-
180C>G polymorphisms  in  the  resistin  gene  in  girls  with  anorexia  nervosa,  and  to  analyse
correlations between variants of these polymorphisms and the level of resistin in blood serum of
the subjects. 
Material and methods 
The study covered 472 girls aged 11–19 years, including 308 girls with the restrictive form of
anorexia nervosa (AN) and 164 healthy girls (C). All the study subjects came from the region of
Silesia. The present study is complementary to our research (not published thus far) focusing on
the assessment of the frequency of ADIPOQ c.45T>G and ADIPOQ c.276G>T polymorphisms in
the adiponectin coding gene. It covers the same group of girls treated in Clinical Hospital No. 1
in Zabrze and a group of healthy subjects (Tab. 1). The AN group included patients suffering
from the restrictive form of anorexia nervosa, diagnosed based on the ICD-10 [3] and DSM-5 [4]
criteria after ruling out other somatic and mental disorders that could have been the cause of
emaciation. Tests were carried out prior to the therapy onset, during the first three days after
admission. The condition for taking blood samples for hormonal tests was a stable status of the
patients and no features of dehydration. The preliminary results of additional tests (electrolytes,
AspAT, AlAT, creatinine) allowed us to rule out acute and chronic liver and kidney diseases. 
The control group (C) consisted of girls with normal body weight, healthy as of the time of the
study, with no chronic diseases, who had not been on any medications in the previous month, and
who had not been on any slimming diet and had not been using any other slimming method over
the previous three months. 
Informed consent for taking part in the study was obtained from the subject’s parents /  legal
guardians and by the subject herself if aged > 16 years. 
The Bioethics Committee of the Medical University of Silesia in Katowice issued permission to
conduct the study (Decision No. KNW/0022/KB1/108/1/11 dated 20 September 2011).
The present study used the data on the subjects’ body mass, height, BMI, and BMI-SDS
obtained in measurements performed during the previous study referred to above. 
The molecular tests were carried out in the Department of Genetics (Institute of Psychiatry and
Neurology, Warsaw) with the use of DNA isolated from frozen samples of peripheral blood. The
isolation  was  obtained  by means  of  a  commercial  Genomic  Mini  Ax Blood Spin  kit  (A&A
Biotechnology, Gdynia, Poland). 
The analysis of selected polymorphisms in the gene of resistin (RETN) was performed according
to the following schedule: 
— amplification in the PCR reaction of a section of the gene containing a polymorphic locus.
The PCR reaction was conducted in the Thermo Cycle thermal cycler by Bio-Rad with the
application of the NXT Taq PCR kit by EURx, containing the following: hot start NXT
TaqDNA Polymerase,  reaction buffer,  MgCl2,  and dNTPs, and with the application of
relevant F and R starters. 80–150 ng of the tested DNA was added to the reaction mixture.
The reaction was conducted in 10 µL in the following conditions: 3 minutes at 95°C, and
then 35 cycles: 30 seconds at 95°C, 30 seconds at 58°C, and 1 minute at 72°C. The final
stage was a 5-minute incubation of the product of the PCR reaction at 72°C;
— digesting the product of the PCR reaction with a restriction enzyme. The reaction was
conducted for 1 hour at a temperature of 37°C for both enzymes, BseRI and BpiI;
— electrophoretic division of the digestion products obtained in the agarose gel containing
ethidium bromide;
— preparation of photographic documentation;
— statistical analysis of the results obtained. 
The starters applied and the selected restriction enzymes identifying the polymorphic loci
examined are listed below:
RETN gene polymorphism c.62 G > A
Starter F       5’– GCC GAG ACC ACA TGT CAC T – 3’
Starter R      5’ – CCT CCG GGC CTA CTA AAG AA – 3’
Restrictive enzyme BseRI
RETN gene polymorphism c.-180 C > G
Starter F       5’– TTTT GT CAT GTTT GCA TCA GC – 3’
Starter R      5’ –GGG CTG AGC TAA CCA AAT– 3’
Restrictive enzyme BpiI
The Bioethics Committee of the Medical University of Silesia in Katowice issued permission to
conduct the study (Decision No. KNW/0022/KB1/108/1/11 dated 20 September 2011).
Statistical analysis 
The database was drawn up in an Excel spreadsheet by Microsoft (Redmond, Washington,
USA). Statistical  calculations were performed using MedCalc software ver.  19.1.3 (MedCalc,
Ostend, Belgium). The level of  = 0.05 was considered significant. The following parameters of
the descriptive statistics were determined: arithmetic mean, median,  minimum and maximum
value,  lower  and  upper  quartile,  standard  deviation  (SD),  standard  error  (SE),  and  95%
confidence interval around the mean value. For all parameters the conformity of their distribution
with the normal distribution was verified. The conformity assessment applied the Shapiro-Wilk
test. The assessment of differences between the means was performed by means of Student’s t-
test with a separate evaluation of variances and the U Mann-Whitney test. A one-way analysis of
variance ANOVA was also performed. Homogeneity of variances was evaluated by means of
Levene’s test. 
The tests results were presented graphically as a box plot with a mean value and a 95%
confidence interval for the mean value marked as an error bar. An analysis of contingent tables
was performed for  qualitative  variables.  Descriptive  statistics  were calculated:  Pearson’s  chi-
square, the significance level p, and the C contingency coefficient. The results are presented in
graphic form by means of categorised histograms.  
Results
The average age in the AN and C groups was similar (15.06 ± 1.57 years and 15.16 ± 2.12 years,
respectively). The average body weight in the AN group was significantly lower (p < 0.05) than
in the C group (40.21 ± 6.01 kg and 49.87 ± 7.93 kg, respectively). The average BMI and BMI-
SDS in girls with AN were significantly lower (p < 0.05) than in the healthy girls (BMI: 15.19 ±
1.67 kg/m2 vs. 20.12 ± 2.46 kg/m2, BMI-SDS: –2.53 ± 0.96 vs. 0.12 ± 1.06, respectively) (Tab. 1).
The average RES level in blood serum in the AN group was significantly lower (p<0.0001) than
in the C group (2.60 ± 0.62 ng/mL and 5.65 ± 2.42 ng/mL, respectively) (Tab. 1; Fig. 1).
The frequency of genotypes in the RETN c.62 and RETN c.-180 polymorphic site of the resistin
gene in both groups (AN and C) is depicted in Table 2 and Figures 2 and 3. 
The most  frequent  genotype in  the  RETN c.62  polymorphic site  of the resistin  gene in  both
groups was the GG genotype. The GA genotype in this gene was more frequent in girls with AN
as compared to the healthy subjects (Tab. 2; Fig. 2). The most frequent genotype in the RETN c.-
180 polymorphic site in the AN patients was the CG genotype, then the CC genotype, and the
least frequent was the GG genotype; whereas, in the healthy subjects the CC genotype was the
most often observed, then the CG genotype, and the least frequent was the GG genotype (Tab. 2,
Fig. 3). 
The distribution of genotypes in the RETN c.62 polymorphic site of the resistin gene was similar
in both groups (AN and C) and did not differ statistically significantly (p = 0.059). However, a
statistically significant difference was observed in the distribution of genotypes in the RETN c.-
180 polymorphic site of the resistin gene between the AN and C groups (p = 0.0145) (Fig. 3). 
The frequency of single alleles in RETN c.62 polymorphic sites in both groups was similar, and
no statistically significant differences were observed in this respect. The G allele occurred more
frequently than the A allele in the RETN c.62 polymorphic site (Tab. 3, Fig. 4). 
Statistically significant differences were demonstrated in the distribution of C and G alleles in the
RETN c.-180 polymorphic site between the AN group and the C group (p < 0.0001). The C allele
occurred significantly more frequently than the G allele in the group of healthy girls than in the
subjects with AN (Tab. 3, Fig. 5). 
In the entire group of the studied girls (AN and C) a statistically significant positive correlation
between the RES level in blood serum and the body weight (r = 0.42; p < 0.0001) and BMI (r =
0.61; p < 0.0001) was observed (Fig.  6 and 7). No statistically significant relationships were
observed between these parameters in individual groups (AN and C). 
No relationship between the RES concentration in blood serum and the distribution of genotypes
in the investigated polymorphic sites of the resistin gene were observed (Tab. 4). 
Discussion
Following the data from literature pertaining to the influence of polymorphisms located in the
3`UTR region, as well as in the sequence preceding the gene upon the expression of the resistin
gene, we selected two polymorphic sites for our study: RETN c.62 G>A and RETN c.-180 C>G.
The tests  we performed demonstrated that girls suffering from  anorexia nervosa are different
from  healthy  subjects  in  terms  of  the  frequency  of  genotypes  in  the  RETN  c.-180  C>G
polymorphic site of the resistin gene.  The most common genotype in AN patients is the CG
genotype,  and  in  healthy  subjects  —  the  CC  genotype.  Also,  the  single  C  allele  occurs
significantly more frequently than the G allele  in  healthy girls  than in girls  with AN in this
polymorphic site. Other authors [25] have also observed that the C allele is more common in this
locus in healthy women than in women suffering from AN. 
In our pilot study [26] we observed similar differences in terms of the frequency of CC and GG
homozygotes and CG heterozygotes in the  RETN  c.-180 C>G polymorphic site of the resistin
gene between the group of healthy subjects and the AN patients. The CG genotype (p < 0.05)
occurred significantly more frequently in the AN group than in healthy subjects (47.69% vs.
28.95%) (p < 0.05). The control group was dominated by the CC genotype as compared to the
AN group (57.89% vs. 28.95% (p < 0.05). Therefore, the CG genotype in this site of the resistin
gene seems to constitute one of the factors predisposing to anorexia nervosa. 
Smith et al.  [20] investigated the functionality of the -180 C>G polymorphism in the resistin
gene. They demonstrated higher levels of mRNA resistin in the subcutaneous adipose tissue of
the abdomen in GG homozygotes in the RETN c.-180 C>G polymorphic site as compared to CG
and  CC  homozygotes.  Furthermore,  they  demonstrated  a  positive  correlation  between  the
expression of mRNA resistin on one hand and insulin resistance and fat content in the liver on the
other. This could be indicative of the possible significance of this variant of the RETN gene in the
pathogenesis of AN. 
Engert et al. [27] claimed that variant 5’ of human resistin, g.−420 C> G (the same polymorphism
as  c.−180  C>  G  named  with  a  different  numbering  system),  is  associated  with  obesity.  In
Canadian  populations  of  patients  with  diabetes,  obesity,  and  a  control  group  they  observed
significantly higher BMI values (p = 0.03) in individuals with the CG and GG genotypes in
comparison  to  CC homozygotes  in  this  polymorphic  site  of  the  resistin  gene.  They did  not
confirm,  however,  the  described  relationship  for  this  promotor  variant  in  the  Scandinavian
population. 
The  RETN c.−180  polymorphic  site  has  been  investigated  by  other  authors;  they  did  not,
however,  detect  any  relationship  between  this  single  nucleotide  polymorphism  (SNP)  with
obesity [28, 29]. Summing up, there is a consensus that SNP -180 C>G is not related to obesity
(when  investigating  each  genotype  separately),  but  in  certain  populations  or  in  other
circumstances, which have not been determined yet, the GG genotype may predispose to a higher
content of the adipose tissue. 
When choosing the  RETN c.62 G>A polymorphic site for our study, we took into account the
associations of c.62AA and c.62AG with a reduced risk and of c.62GG with an increased risk of
the development of the type 2 diabetes and hypertension, discovered by Tan et al. [30]. Tan et al.
studied 1102 Chinese patients with type 2 diabetes and 743 patients without diabetes. Subjects
suffering from type 2 diabetes exhibited a lower frequency of the occurrence of the A allele of the
resistin gene in the RETN c. 62 site (the frequency of the GG and GA/AA genotypes was 83.5%
and 16.5%, respectively) than subjects from the control group (GG:GA/GA, 75.1% vs. 24.9%; p
< 0.001).  In  patients  with  diabetes  and the  GG genotype  hypertension  was  more  frequently
observed  (GG  GA/AA,  49.8%  vs.  36.2%;  p  =  0.001).  Further  analyses  confirmed  that  the
presence  of  the  G  allele  in  the  RETN  c.62  polymorphic  site  acts  as  an  independent  factor
contributing to type 2 diabetes and hypertension. These results were suggestive of a possible role
of  resistin  in  the  pathogenesis  of  type  2  diabetes  and  hypertension  associated  with  insulin
resistance [30]. 
Observations of these authors have not been confirmed in any other studies. For example, Gouni-
Berthold et al. [31] investigated 384 patients with type 2 diabetes (224 males and 160 females)
with 434 individuals without diabetes constituting a control group (248 males and 186 females)
from the German Caucasian population, in terms of the relationship between this polymorphism
and type 2 diabetes, hypertension, the level of lipoproteins, and the RES concentration in blood,
as well  as atherosclerosis. The A allele in the + 62G > A polymorphic site in the RES gene
occurred in 34 subjects from the control group and 24 subjects with diabetes (frequencies of the
alleles: 4% and 3.2%, respectively). The frequency of genotypes was similar in subjects with type
2 diabetes (93.75% and 6.25%, respectively, for GG:GA/AA) and without diabetes (92.2% and
7.8%, respectively for GG:GA/AA) (p = 0.31). In carriers of the A allele in the control group and
in the entire investigated cohort hypertension occurred significantly more frequently (p = 0.039
and p = 0.005, respectively). Such a relationship did not occur in subjects with diabetes.  No
relationship between the investigated polymorphism and BMI, the presence of atherosclerosis,
the level of triglycerides, HDL, and LDL cholesterol was detected, both in the control group and
the group of subjects with diabetes. Similarly, no difference in the RES concentration in blood
between  carriers  and  non-carriers  of  variant  A in  this  polymorphic  site  was  demonstrated.
Summing  up,  the  study  demonstrated  that  in  the  German  Caucasian  population  variant  A
occurring in the RETN c.62 polymorphic site of the RES gene is associated with hypertension but
not with type 2 diabetes [31]. 
In the Czech population, authors [25] compared the frequency of single alleles in the RETN c.62
G>A polymorphic site of the resistin gene in obese subjects (BMI: 43.48 ± 1.12 kg/m2),  AN
patients  (BMI:  15.72  ±  0.36  kg/m2),  and in  healthy females  (BMI:  22.32  ± 0.40  kg/m2).  In
patients with AN they demonstrated — as we did in our study — that the most frequent allele in
the locus RETN c.62 G>A of the resistin gene is the G allele (100% and 93.8%, respectively). 
As well as studying the frequency of single alleles in these polymorphic sites, we also analysed
the  frequency of  genotypes.  We demonstrated  that  the  most  frequent  genotype  was  the  GG
genotype  in  both  groups;  we  did  not  detect  the  AA genotype  in  any  of  the  subjects.  The
distribution of genotypes in the RETN c.62 G>A polymorphic sites of the resistin gene in the AN
patients  examined by us  does  not  differ  from the  distribution  of  these  genotypes  in  healthy
subjects. We made similar observations in our pilot study. This could confirm that the genotype in
this locus does not have any influence on the predisposition to develop AN. 
We demonstrated significantly lower concentrations of RES in blood serum in girls with AN than
in healthy subjects (p < 0.0001). The RES concentration correlates positively with the body mass
and BMI in all the study subjects jointly (p < 0.0001). Similar observations have been made by
other authors [32], as well as by us in our pilot study [26]. 
Ziora et al. [24] observed that the group of girls with AN demonstrated a significantly lower RES
concentration in blood serum (3.87 ng/mL) as compared to healthy subjects. In 87 girls with the
restrictive form of AN, 17 girls with “nonspecific eating disorders”, 30 obese, and 61 healthy
girls with a normal body weight, it was demonstrated that the average concentrations of resistin
in blood of the girls with AN (2.8 ng/mL) were nearly two-fold lower as compared to healthy
subjects  (4.1 ng/mL) and obese  girls  (4.8 ng/mL).  In  all  the  study subjects  jointly,  the RES
concentration  correlated  positively  with  BMI.  Conversion  of  blood  resistin  levels  into  BMI
indicated that in girls suffering from AN the values of resistin levels in blood/BMI were higher
than in obese girls (unlike the absolute values), albeit close to the values obtained for healthy
girls. 
Křížova et al. [25] obtained similar results when comparing blood resistin levels in 28 females
with AN and selecting — besides healthy subjects — an additional group of 77 obese women.
They observed  significantly  lower  resistin  concentrations  in  blood  in  AN patients  quoted  in
absolute values (3.99 ± 0.33 ng/mL) as compared to obese subjects (8.11 ± 0.60 ng/mL; p <
0.001) and healthy women (6.27 ± 0.50 ng/mL; p < 0.05).
Dolezalova et al. [33], who investigated the influence of chronic malnutrition on the endocrine
function of the adipose tissue in 12 females with the restrictive form of anorexia nervosa, did not
detect any differences in blood RES levels in the AN group as compared to the group of healthy
women. They did, however, demonstrate a significantly higher expression of mRNA resistin and
a lower expression of IL-6 and the immunocompetent cells marker (CD 68) in the subcutaneous
adipose tissue in AN patients as compared to healthy subjects. On the basis of these observations,
the authors conclude that local changes in the mRNA resistin expression in the adipose tissue
may not reflect the blood levels of this hormone in AN. 
On the other hand, other authors [34] did not detect any significant differences between average
RES levels in patients with the restrictive (3.44 ng/mL) and bulimic-purgatory form of AN (5.12
ng/mL) nor in AN female patients (4.36 ng/mL) as compared to healthy subjects (4.38 ng/mL). In
none of the investigated groups researchers observed any correlations between the blood RES
levels on one hand and BMI and the adipose tissue content on the other. Hence they concluded
that the concentration of resistin in blood is not related to the nutritional status. 
In healthy subjects a positive relationship between the RES concentration in blood on one hand
and the quantity of the adipose tissue and BMI on the other was demonstrated [32]. In our studies
[24, 35] we also observed a strong positive relationship between the RES level in blood and BMI
jointly in all the study subjects (r = 0.66; p < 0.0001); there was, however, no correlations in
individual groups, regarded separately. This could have been associated — like in the study by
Housova et al. [34] — with a small spread of the values of resistin levels and BMI within an
individual group. 
A drop in the blood resistin level can be a consequence not only of malnutrition, but also of a
reduced production of this hormone in the bone marrow, or an increase of the resistin clearance,
or it could be an effect of a disfunction of mononuclears/macrophages and impaired production of
such cytokines as TNF and IL-6, which enhance the RES expression in macrophages [16, 36–38].
Our previous study [24] demonstrated that the elimination of the influence of the body mass
factor  on  the  values  of  determined  resistin  levels  in  blood  by  converting  the  blood  RES
concentrations into BMI indicates that the quantity of this hormone in blood in girls suffering
from AN is in fact comparable with healthy subjects and definitely higher than in obese subjects.
This may be connected with an enhanced production of this hormone in other organs and tissues
(e.g. macrophages), and not only in the adipose tissue, in AN patients. 
The relationship between resistin and body mass in humans still remains controversial [39, 40],
since the relationships between the level of this hormone in blood and the body mass in obese
subjects in the opinions of the authors cited above are divergent. Perhaps the polymorphism of
the RES gene and the carrier-state for the G allele in the site -180 of the RES gene has a positive
influence  on  the  increase  of  the  BMI.  In  our  studies  we  did  not  observe  any  statistically
significant relationships between the blood plasma resistin level and the genotype in both  loci:
RETN c.62 G>A and RETN c.-180 of the RES gene in girls suffering from anorexia nervosa and
in healthy subjects, similarly to the pilot study; we did not, however, examine obese girls. 
We are  aware  of  certain  limitations.  Association  studies  of  psychiatric  disorders  are  usually
underpowered due to the small sample sizes. As the access to AN patients is lower than in other
population studies, hence the study spanned several years. We decided on the final sizes of the
studied groups having taken into account the subject literature devoted to association studies,
adjusting our technical and financial abilities as much as possible. Another limitation is the fact
that the blood plasma resistin levels in AN patients were not determined in all patients, and if
they were, it was carried out in the acute phase of the illness, caused by starvation and a low
content of the adipose tissue. Nevertheless, from the statistical perspective a group of this size is
sufficient for hormonal studies. One needs to bear in mind also that it is the acute phase of the
illness  that  constitutes  the  most  distinct  feature  of  differentiating  AN  patients  and  healthy
subjects. Numerous adaptive mechanisms of the body can be observed in such cases, including
hormonal ones, which is a very interesting phenomenon. 
Based on the results obtained in our study, we conclude that the CG genotype in the RETN c.-180
C>G polymorphic site of the resistin gene may constitute one of the factors predisposing to the
development of AN in girls. 
Furthermore, we believe that the genotype of the resistin gene in the RETN c.62 G>A and RETN
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Table 1. Characteristics of examined girls with anorexia nervosa (AN) and healthy girls (C) and




(n = 164) 
Mean  SD (range) Mean  SD (range)
Age [years] 15.06  1.57 (11–19) 15.16  2.12 (11–19)
Height [cm] 162.47  6.47 (143.0–177.0) 160.31  7.06 (142.0–175.0)
Body weight [kg] 40.21  6.01 (18.7–54.8) 49.87*  7.93 (30.2–65.0)
BMI [kg/m2] 15.19  1.67 (9.11–18.6) 20.12*  2.46 (13.9–26.13)
BMI-SDS –2.53  0.96 (–5.49– –1.94) 0.12*  1.06 (–2.17– 2.0)
Resistin [ng/mL] 2.60 ± 0.62 (1.09–3.99) 5.65** ± 2.42 (2.56–11.46)
SD — standard deviation; BMI —body mass index; BMI-SDS — body mass index-standard
deviation score (subjects’ BMI from the mean BMI for age and gender); AN vs. C * p < 0.05; AN
vs. C **p < 0.0001
Table 2.  The genotype frequency in the polymorphic sites of the resistin gene (RETN c.62 and







n = 308 n = 163
p = 0.059; c = 0.087
RETN c.62
GA 38 (12.3%) 11 (6.7%)
GG 270 (87.7%) 152 (93.3%)
AA 0 (0%) 0 (0%)  
n = 306 n = 155
p = 0.0145; c = 0.134
RETN c.-180
CC 119 (38.9%) 78 (50.3%)*
CG 136 (44.4%) 64 (41.3%)*
GG 51 (16.7%) 13 (8.4%)*
C vs. AN *p < 0.05
Table 3. The allele frequency in the polymorphic sites of the resistin gene (RETN c.62 and RETN







n = 308 n = 163
p = 0.059; c = 0.087
RETN c.62
G 578 (93.8%) 315 (96.65%)
A 38 (6.2%) 11 (3.4%)
n = 306 n = 155
p < 0.0001; c = 0.133
RETN c.-180
C 375 (61.4%) 232 (74.8%)*
G 236 (38.6%) 78 (25.2%)*
C vs. AN *p < 0.0001
Table  4.  Mean  concentration  of  resistin  in  the  serum  depending  on  the  genotype  in  the
polymorphic  site  of  the  resistin  gene  (RETN c.62 and  RETN c.-180)  in  examined girls  with
anorexia nervosa (AN) and healthy controls (C)
Examined gene
Genotype
Resistin in serum [ng/mL]
AN (n = 172) C (n = 129)










































































Figure 1. Serum resistin concentrations in girls with anorexia nervosa (AN) and healthy controls
(C). AN vs. C p < 0.0001
 

















Figure 3.  Distribution of genotypes in locus  RETN c.-180 in girls with  anorexia nervosa (AN)
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Figure 4. Distribution of G and A alleles in RETN c.62 polymorphic site in girls with anorexia
nervosa (AN) and healthy controls (C) 
Figure 5. Distribution of G and C alleles in RETN c.-180 polymorphic site in girls with anorexia























Figure  6.  Correlation  between  serum resistin  level  and  body weight  in  girls with anorexia
nervosa (AN) and healthy controls (C)
 
 
Figure 7. Correlation between serum resistin level and BMI in girls with anorexia nervosa (AN)
and healthy controls (C)
